TrialLancet (London, England)2023

Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies.

William J Sandborn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.